EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study

Masuma Hoque, Deok Ryun Kim, Faisal Ahmmed, Md Taufiqul Islam, Justin Im, Birkneh Tilahun Tadesse, Sophie Kang, Farhana Khanam, Fahima Chowdhury, Tasnuva Ahmed, Md Golam Firoj, Asma Binte Aziz und 12 weitere

The Lancet Microbe · 2025

DOI: 10.1016/j.lanmic.2024.100981 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Lancet Microbe, 2025. Verfasst von Masuma Hoque und 23 weiteren Autor:innen. Beteiligte Einrichtung: International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Cholera. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with cholera have been shown to be protected against subsequent cholera for 3 years after their initial episode. We aimed to assess protection at 10 years of follow-up. METHODS: In this retrospective cohort study, cohorts of patients treated for cholera (index patients) and contemporaneously selected age-matched individuals without cholera (controls), randomly selected from the population of Matlab, Bangladesh, were assembled between 1990 and 2009 and followed for up to 10 years. Selection of participants who had no history of cholera in the 5 years before selection proceeded in secular sequence, and selection was done without replacement. Protection against subsequent treated cholera was assessed in proportional hazards models and waning of protection was assessed non-parametrically with use of smoothing of protection curves. FINDINGS: We included 3925 index patients and 23 550 matched controls. Patients with El Tor cholera (26 subsequent episodes among 3619 index patients) had a 48·6% (95% CI 23·1 to 65·7; p=0·0012) lower risk of El Tor cholera than controls, with no evidence of waning during up to 10 years of follow-up (p=0·87). Index patients aged 5 years and older with El Tor cholera (nine subsequent episodes among 2279 index patients) were at a 61·7% (23·6 to 80·8; p=0·0065) lower risk of El Tor cholera, whereas index patients younger than 5 years with El Tor cholera (17 subsequent episodes among 1340 index patients) had a 36·2% (-5·0 to 61·3; p=0·077) lower risk (p=0·26 for the difference by age). INTERPRETATION: Protection against El Tor cholera associated with previous El Tor cholera was moderate in magnitude and sustained over 10 years of follow-up. These findings suggest the potential for sustained, long-term protection by oral cholera vaccines in populations with endemic cholera and help inform models of cholera in endemic settings. FUNDING: Bill & Melinda Gates Foundation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholeraHumansBangladeshRetrospective StudiesMaleFemaleChild, PreschoolAdultFollow-Up StudiesChildAdolescentYoung AdultMiddle AgedInfantVibrio choleraeCholera Vaccines

Substanzen

Cholera Vaccines

Autor:innen und Institutionen

  • International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
  • International Vaccine Institute, Seoul, South Korea.
  • National Institute of Cholera and Enteric Diseases, Kolkata, India.
  • International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland; Division of Tropical and Humanitarian Medicin…
  • Department of Microbiology and Immunology, University of Goteborg, Goteborg, Sweden.

Förderung

  • Gates Foundation
  • Bill and Melinda Gates Foundation

Zitieren

APA

Hoque, M., Kim, D. R., Ahmmed, F., Islam, M. T., Im, J., Tadesse, B. T., Kang, S., Khanam, F., Chowdhury, F., Ahmed, T., Firoj, M. G., Aziz, A. B., Kanungo, S., Khan, A. I., Khan, M. A., Lee, J., Pak, G., Marks, F., Kim, J. H., …, & Clemens, J. D. (2025). Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study. The Lancet Microbe. https://doi.org/10.1016/j.lanmic.2024.100981

Vancouver

Hoque M, Kim DR, Ahmmed F, Islam MT, Im J, Tadesse BT, et al. Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study. The Lancet Microbe. 2025. doi:10.1016/j.lanmic.2024.100981

BibTeX
@article{Hoque2025,
  author = {Hoque, Masuma and Kim, Deok Ryun and Ahmmed, Faisal and Islam, Md Taufiqul and Im, Justin and Tadesse, Birkneh Tilahun and Kang, Sophie and Khanam, Farhana and Chowdhury, Fahima and Ahmed, Tasnuva and Firoj, Md Golam and Aziz, Asma Binte and Kanungo, Suman and Khan, Ashraful Islam and Khan, Md Alfazal and Lee, Jooah and Pak, Gideok and Marks, Florian and Kim, Jerome H and Azman, Andrew and Holmgren, Jan and Qadri, Firdausi and Zaman, Khalequ and Clemens, John D},
  title = {Protection by natural cholera against later episodes of cholera over 10 years of follow-up in Matlab, Bangladesh: a retrospective cohort study},
  journal = {The Lancet Microbe},
  year = {2025},
  doi = {10.1016/j.lanmic.2024.100981}
}
Kostenlos starten →